AstraZeneca Pharmaceuticals

AstraZeneca is a global science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company was formed in 1999 through the merger of the Swedish company Astra AB and the British Zeneca Group. Today, it is one of the world's largest pharmaceutical companies, known for its work across oncology, cardiovascular, renal, metabolism, and respiratory diseases.

Manufacturing for AstraZeneca is a highly distributed global operation, with major production facilities located in the United Kingdom, Sweden, the United States, China, and Puerto Rico, among others. This international supply chain ensures that their medicines, including well-known vaccines and therapeutic treatments, reach patients in over 100 countries.

AstraZeneca PLC is a publicly traded company listed on the London, Stockholm, and Nasdaq stock exchanges. While it maintains its corporate headquarters in Cambridge, United Kingdom, its operations remain deeply rooted in both British and Swedish industrial heritage. The company continues to invest heavily in research and development to maintain its position as a leader in global healthcare innovation.